Hollow microneedle and microneedle array chip

By optimizing the connection structure and liquid flow channel design between the needle rod and the needle holder in the hollow microneedle, the problems of microneedle fracture and drug liquid leakage are solved, and the structural strength and drug delivery efficiency are improved.

WO2024245028A1PCT designated stage expired Publication Date: 2024-12-05CHONGQING JINSAIXING MEDICAL TECH CO LTD

Patent Information

Application Number
PCT/CN2024/094207
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-26
Filing Date
2024-05-20
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Existing microneedles are prone to break when pierced into the skin, have insufficient structural strength, and the liquid is prone to seep out, affecting the efficiency of drug delivery.

Method used

A hollow microneedle is designed, and the connection between the needle rod and the needle holder forms a transition chamfer to form a multi-channel liquid flow channel structure, and the medicine liquid passes through the third liquid flow channel, the second liquid flow channel and the first liquid flow channel. The channel flows out, and the liquid discharge angle of the first liquid flow channel is adjustable to reduce the risk of liquid leakage.

Benefits of technology

It improves the structural strength of the hollow microneedle, reduces the risk of breaking the needle, reduces the leakage of the drug liquid, and improves the drug delivery efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2024094207_05122024_PF_FP_ABST
    Figure CN2024094207_05122024_PF_FP_ABST
Patent Text Reader

Abstract

A hollow microneedle (1) and a microneedle array chip (2). The hollow microneedle (1) comprises a needle tip (10), a needle shaft (11), and a needle base (12); the needle tip (10), the needle shaft (11), and the needle base (12) are sequentially connected in the axial direction of the hollow microneedle (1); a transition chamfer (113) is formed at the joint of the needle shaft (11) and the needle base (12); a first liquid flow channel (101) is formed in the needle tip (10), a second liquid flow channel (111) is formed in the needle shaft (11), and a third liquid flow channel (121) is formed in the needle base (12); the first liquid flow channel (101), the second liquid flow channel (111), and the third liquid flow channel (121) are communicated; and an included angle between a first central axis of the first liquid flow channel (101) and a second central axis of the second liquid flow channel (111) ranges from 0° to 80°. The hollow microneedle (1) of such configuration has good structural strength, the risk of liquid medicine leakage can be reduced, and the administration efficiency is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Hollow microneedles and microneedle array chips

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to Chinese patent application No. 2023106063554, filed on May 26, 2023, entitled “Hollow Microneedles and Microneedle Array Chip,” which is incorporated herein by reference in its entirety. Technical Field

[0003] The present application relates to the field of medical device technology, and in particular to a hollow microneedle and a microneedle array chip. Background Art

[0004] From the outside in, human skin consists of the stratum corneum, the active epidermis, and the dermis. Injection is currently one of the primary routes of administration for most drugs. Microneedle injection is a novel transdermal delivery method that can penetrate the stratum corneum to form a drug delivery channel without stimulating the subcutaneous pain nerves. Compared to traditional subcutaneous injection, microneedle injection can inject drugs directly into the dermis rather than the subcutaneous tissue or muscle, reducing pain for patients, leading to higher compliance, less fear of injections, and relatively higher safety.

[0005] In the prior art, microneedles used in microneedle injection primarily include solid microneedles, hollow microneedles, soluble microneedles, coated microneedles, and hydrogel microneedles. Compared to other microneedle types, hollow microneedles can provide a higher drug loading capacity without changing the drug formulation. The forces exerted on the skin when a microneedle penetrates mainly include axial pressure, lateral pressure, shear force, and friction. The thickness of the stratum corneum in the skin is approximately 10-20 μm, the thickness of the active epidermis is approximately 50-100 μm, and the thickness of the dermis is approximately 1000 μm. Because the dermis contains nerve endings, the length of a microneedle is generally not more than 1000 μm. Otherwise, the patient will experience pain or even bleeding after the microneedle tip penetrates the skin. Multiple microneedles can also be arranged in an array to form a microneedle array chip structure, providing more efficient microneedle injection. Existing microneedles still use a conventional structure with a beveled tip and an opening, which can easily cause drug solution to seep out of the skin surface, affecting drug delivery efficiency. At the same time, microneedles are prone to breakage during use, and their structural strength still needs to be improved.

[0006] Summary of the Invention

[0007] In order to solve at least one of the technical problems existing in the background technology, the present application provides a hollow microneedle with good structural strength, which can reduce the risk of drug leakage and improve drug delivery efficiency.

[0008] The present application also provides a microneedle array chip.

[0009] The first embodiment of the present application provides a hollow microneedle, comprising:

[0010] A needle tip, a needle shaft, and a needle seat, wherein the needle tip, the needle shaft, and the needle seat are sequentially connected along the axial direction of the hollow microneedle, and a transition chamfer is formed at the connection between the needle shaft and the needle seat;

[0011] A first liquid flow channel is formed in the needle tip, a second liquid flow channel is formed in the needle shaft, and a third liquid flow channel is formed in the needle seat;

[0012] The first liquid flow channel, the second liquid flow channel and the third liquid flow channel are connected;

[0013] An included angle between a first central axis of the first liquid flow channel and a second central axis of the second liquid flow channel ranges from 0° to 80°.

[0014] According to the hollow microneedle provided in the embodiment of the first aspect of the present application, the overall structural strength of the hollow microneedle is improved by optimizing the connection structure between the needle rod and the needle seat, and the risk of drug leakage is reduced by optimizing the liquid outlet angle of the first liquid flow channel in the needle tip. Specifically, the hollow microneedle includes a needle tip, a needle rod and a needle seat. The needle tip, the needle rod and the needle seat are connected in sequence along the axial direction of the hollow microneedle, and a transition chamfer is formed at the connection between the needle rod and the needle seat. This allows for a smooth transition between the needle rod and the needle seat, reduces stress concentration at the connection between the needle rod and the needle seat, and thus avoids the hollow microneedle from breaking at the connection between the needle rod and the needle seat during the process of piercing the skin, reduces the risk of needle breakage, and enhances the structural strength of the hollow microneedle; a first liquid flow channel is formed in the needle tip, a second liquid flow channel is formed in the needle rod, and a third liquid flow channel is formed in the needle seat, and the first liquid The flow channel, the second liquid flow channel and the third liquid flow channel are connected to facilitate the circulation of the liquid medicine. The liquid medicine passes through the third liquid flow channel, the second liquid flow channel and the first liquid flow channel in turn, and flows out of the first liquid flow channel, wherein the angle between the first central axis of the first liquid flow channel and the second central axis of the second liquid flow channel ranges from 0° to 80°. The exit angle of the liquid medicine when flowing through the first liquid flow channel is diversified, and the direction of liquid flow changes, which can reduce the flow speed and pressure, thereby reducing the risk of exudation, and can better release the liquid medicine into the skin tissue. In summary, the hollow microneedle provided in the embodiment of the present application has good structural strength, and can reduce the risk of drug exudation and improve drug delivery efficiency.

[0015] According to one embodiment of the present application, the end of the needle tip facing away from the needle shaft forms a pointed top, and the end of the needle tip facing the needle shaft forms a pointed bottom, and the radial cross-sectional area of ​​the needle tip decreases from the pointed bottom to the pointed top.

[0016] A connecting surface is formed between the pointed top portion and the pointed bottom portion, and a liquid outlet of the first liquid flow channel is formed on the connecting surface.

[0017] According to one embodiment of the present application, the connecting surface includes an intersecting bevel surface, a first annular side surface, a first side plane, and a second side plane, the first side plane and the second side plane intersect at a first intersection line, the liquid outlet is formed on the bevel surface, the angle between the bevel surface and the first intersection line ranges from 20° to 80°, and the angle between the bevel surface and the axis of the hollow microneedle ranges from 20° to 80°;

[0018] Alternatively, the connecting surface includes an intersecting beveled surface, a first annular side surface, a first side plane, and a second side plane, wherein a first transition connecting surface is formed at the intersection of the first side plane and the second side plane, and an angle between the beveled surface and the first transition connecting surface ranges from 20° to 80°, and an angle between the beveled surface and the axis of the hollow microneedle ranges from 20° to 80°;

[0019] Alternatively, the connecting surface is a conical surface, and the liquid outlet is formed on the conical surface.

[0020] According to one embodiment of the present application, the length of the second liquid flow channel is greater than or equal to 100 μm;

[0021] The total volume of the first liquid flow channel and the second liquid flow channel accounts for 30%-80% of the total volume of the needle tip and the needle shaft.

[0022] According to one embodiment of the present application, the first end of the needle rod faces the needle seat, the second end of the needle rod faces the needle tip, and the radial cross-sectional area of ​​the needle rod decreases from the first end of the needle rod to the second end of the needle rod.

[0023] According to one embodiment of the present application, the needle rod is a cone structure, and the cone includes a second annular side surface, a third side plane, and a fourth side plane that are connected and surrounded;

[0024] The third side plane intersects the fourth side plane at a second intersection line, the second intersection line is parallel to the axis of the hollow microneedle, and the second annular side surface is inclined toward the second intersection line;

[0025] Alternatively, a second transition connection surface is formed at the intersection of the third side plane and the fourth side plane, the second transition connection surface is parallel to the axis of the hollow microneedle, and the second annular side surface is inclined toward the second transition connection surface.

[0026] According to one embodiment of the present application, the needle rod includes at least two main body parts;

[0027] The radial cross-sectional area change rate of at least one of the main body portions is different from the radial cross-sectional area change rates of the other main body portions, or the radial cross-sectional area change rates of all the main body portions are the same.

[0028] According to one embodiment of the present application, the first end of the needle seat faces away from the needle rod, and the second end of the needle seat faces toward the needle rod;

[0029] The radial cross-sectional area of ​​the first end of the needle seat is greater than or equal to the radial cross-sectional area of ​​the second end of the needle seat;

[0030] The radial cross-sectional area of ​​the second end of the needle seat is greater than or equal to the radial cross-sectional area of ​​the first end of the needle rod;

[0031] The diameter of the first end of the needle seat is greater than or equal to 200 μm, and the distance between the first end of the needle seat and the second end of the needle seat is greater than or equal to 100 μm.

[0032] According to one embodiment of the present application, the diameter D of the first end of the needle rod is in the range of 10 μm-200 μm, the total length L of the needle tip and the needle rod is in the range of 200 μm-1000 μm, and L / D≥2.

[0033] A second embodiment of the present application provides a microneedle array chip, comprising:

[0034] a base, wherein a receiving cavity suitable for receiving the liquid medicine is formed in the base;

[0035] and at least two hollow microneedles according to any one of the embodiments of the first aspect described above;

[0036] The hollow microneedle is arranged on the base, and the accommodating cavity is connected to the third liquid flow channel. BRIEF DESCRIPTION OF THE DRAWINGS

[0037] In order to more clearly illustrate the technical solutions in the present application or the prior art, a brief introduction will be given below to the drawings required for use in the embodiments or the description of the prior art. Obviously, the drawings described below are some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without any creative work.

[0038] FIG1 is a schematic structural diagram of a hollow microneedle provided in an embodiment of the present application;

[0039] FIG2 is a cross-sectional view of the structure of the hollow microneedle shown in FIG1 ;

[0040] FIG3 is a second structural diagram of a hollow microneedle provided in an embodiment of the present application;

[0041] FIG4 is an axonometric schematic diagram of the hollow microneedle shown in FIG3 ;

[0042] FIG5 is a second axonometric diagram of the hollow microneedle shown in FIG3 ;

[0043] FIG6 is a first structural diagram of a microneedle array chip provided in an embodiment of the present application;

[0044] FIG7 is a second structural diagram of a microneedle array chip provided in an embodiment of the present application;

[0045] FIG8 is a third structural diagram of the microneedle array chip provided in an embodiment of the present application.

[0046] Figure numerals: 1. hollow microneedle; 2. microneedle array chip; 10. needle tip; 101. first liquid flow channel; 1011. liquid outlet; 102. connecting surface; 1021. beveled surface; 1022. first annular side surface; 1023. first side plane; 1024. second side plane; 1025. first intersection line; 1026. first transition connecting surface; 11. needle rod; 111. second liquid flow channel; 113. transition chamfer; 114. second annular side surface; 115. third side plane; 116. fourth side plane; 117. second intersection line; 118. second transition connecting surface; 12. needle seat; 121. third liquid flow channel; 20. base. DETAILED DESCRIPTION

[0047] To make the objectives, technical solutions, and advantages of this application more clear, the technical solutions of this application will be clearly and completely described below in conjunction with the accompanying drawings. Obviously, the embodiments described are only part of the embodiments of this application, not all of them. Based on the embodiments of this application, all other embodiments obtained by ordinary technicians in this field without making any creative efforts are within the scope of protection of this application.

[0048] In the description of the embodiments of the present application, it should be noted that the terms "center", "longitudinal", "lateral", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inside", "outside", etc., indicating the orientation or positional relationship, are based on the orientation or positional relationship shown in the accompanying drawings, and are only for the convenience of describing the embodiments of the present application and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operate in a specific orientation, and therefore cannot be understood as limiting the embodiments of the present application. In addition, the terms "first", "second", and "third" are used for descriptive purposes only and cannot be understood as indicating or implying relative importance.

[0049] In the description of the embodiments of this application, it should be noted that, unless otherwise specified or limited, the terms "connected" and "connection" should be understood in a broad sense. For example, they can refer to fixed connections, detachable connections, or integral connections; they can refer to mechanical connections or electrical connections; they can refer to direct connections or indirect connections through an intermediate medium. Those skilled in the art will understand the specific meanings of the above terms in the embodiments of this application based on the specific circumstances.

[0050] In the embodiments of the present application, unless otherwise expressly specified or limited, a first feature being "above" or "below" a second feature may mean that the first and second features are in direct contact, or that the first and second features are in indirect contact through an intermediate medium. Furthermore, a first feature being "above," "above," and "above" a second feature may mean that the first feature is directly above or obliquely above the second feature, or simply means that the first feature is higher in level than the second feature. A first feature being "below," "below," and "below" a second feature may mean that the first feature is directly below or obliquely below the second feature, or simply means that the first feature is lower in level than the second feature.

[0051] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the embodiments of the present application. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art can combine and combine different embodiments or examples described in this specification and the features of different embodiments or examples, unless they are contradictory.

[0052] As shown in Figures 1 to 5, the first embodiment of the present application provides a hollow microneedle 1, including a needle tip 10, a needle rod 11 and a needle seat 12. The needle tip 10, the needle rod 11 and the needle seat 12 are connected in sequence along the axial direction of the hollow microneedle 1, and a transition chamfer 113 is formed at the connection between the needle rod 11 and the needle seat 12; a first liquid flow channel 101 is formed in the needle tip 10, a second liquid flow channel 111 is formed in the needle rod 11, and a third liquid flow channel 121 is formed in the needle seat 12; the first liquid flow channel 101, the second liquid flow channel 111 and the third liquid flow channel 121 are connected; the angle between the first central axis of the first liquid flow channel 101 and the second central axis of the second liquid flow channel 111 ranges from 0° to 80°.

[0053] The needle tip 10 is the portion of the hollow microneedle 1 that is used to puncture the skin. The liquid medicine also flows out of the needle tip 10. The needle hub 12 can also be called the cutoff portion. When the hollow microneedle 1 penetrates the skin, the needle hub 12 contacts the skin, preventing the hollow microneedle 1 from penetrating deeper into the skin, especially the subcutaneous layer, after penetrating a certain depth, thereby preventing bleeding and pain. The first liquid flow channel 101, the second liquid flow channel 111, and the third liquid flow channel 121 are connected as a whole to form a channel. The liquid medicine flows through the third liquid flow channel 121, the second liquid flow channel 111, and the first liquid flow channel 101 in sequence. The second liquid flow channel 111 can have a variable diameter feature. The diameter of the second liquid flow channel 111 gradually decreases toward the needle tip 10. The first liquid flow channel 101 can also have a variable diameter feature, and the diameter change rate is consistent with the diameter change rate of the second liquid flow channel 111. The angle between the first central axis of the first liquid flow channel 101 and the second central axis of the second liquid flow channel 111 ranges from 0° to 80°. Within this range, the specific angle value can be determined based on actual conditions, making the structural design of the hollow microneedle 1 more diverse and its application scenarios more extensive. Based on the above angle value range, in the embodiments of the present application, the angle between the first central axis of the first liquid flow channel 101 and the second central axis of the second liquid flow channel 111 can be determined to range from 0° to 50°.

[0054] According to the hollow microneedle 1 provided in the embodiment of the first aspect of the present application, the overall structural strength of the hollow microneedle 1 is improved by optimizing the connection structure between the needle rod 11 and the needle seat 12, and the risk of drug leakage is reduced by optimizing the liquid outlet angle of the first liquid flow channel 101 in the needle tip 10. Specifically, the hollow microneedle 1 includes a needle tip 10, a needle rod 11 and a needle seat 12. The needle tip 10, the needle rod 11 and the needle seat 12 are connected in sequence along the axial direction of the hollow microneedle 1. A transition chamfer 113 is formed at the connection between the needle rod 11 and the needle seat 12. This allows for a smooth transition between the needle rod 11 and the needle seat 12, reduces stress concentration at the connection between the needle rod 11 and the needle seat 12, and thereby avoids the hollow microneedle 1 from breaking at the connection between the needle rod 11 and the needle seat 12 during the process of piercing the skin, reduces the risk of needle breakage, and enhances the structural strength of the hollow microneedle 1. A first liquid flow channel 101 is formed in the needle tip 10, a second liquid flow channel 111 is formed in the needle rod 11, and a third liquid flow channel 113 is formed in the needle seat 12. Channel 121, and the first liquid flow channel 101, the second liquid flow channel 111 and the third liquid flow channel 121 are connected to facilitate the circulation of the liquid medicine. The liquid medicine passes through the third liquid flow channel 121, the second liquid flow channel 111 and the first liquid flow channel 101 in turn, and flows out of the first liquid flow channel 101, wherein the angle between the first central axis of the first liquid flow channel 101 and the second central axis of the second liquid flow channel 111 ranges from 0° to 80°. The exit angle of the liquid medicine when flowing through the first liquid flow channel 101 is diversified in design, and the direction of liquid flow changes, which can reduce the flow velocity and pressure, thereby reducing the risk of seepage, and can better release the liquid medicine into the skin tissue. In summary, the hollow microneedle 1 provided in the embodiment of the present application has good structural strength, and can reduce the risk of drug seepage and improve drug delivery efficiency.

[0055] As shown in Figure 1, in an embodiment of the present application, the end of the needle tip 10 facing away from the needle rod 11 forms a pointed top, and the end of the needle tip 10 facing the needle rod 11 forms a pointed bottom, and the radial cross-sectional area of ​​the needle tip 10 decreases from the pointed bottom to the pointed top; a connecting surface 102 is formed between the pointed top and the pointed bottom, and the liquid outlet 1011 of the first liquid flow channel 101 is formed on the connecting surface 102. The decreasing radial cross-sectional area of ​​the needle tip 10 means that the needle tip 10 is in a contracted state when extending from the pointed bottom to the pointed top. Furthermore, the needle tip 10 can contract sharply or slowly. The connecting surface 102 is the side of the needle tip 10, connecting the pointed top and the pointed bottom, and the liquid outlet 1011 of the first liquid flow channel 101 is formed on the connecting surface 102.

[0056] As shown in Figures 3 to 5, in the embodiment of the present application, the connecting surface 102 includes an intersecting bevel surface 1021, a first annular side surface 1022, a first side plane 1023 and a second side plane 1024, the first side plane 1023 and the second side plane 1024 intersect at a first intersection line 1025, the liquid outlet 1011 is formed on the bevel surface 1021, the angle between the bevel surface 1021 and the first intersection line 1025 ranges from 20° to 80°, and the angle between the bevel surface 1021 and the axis of the hollow microneedle 1 ranges from 20° to 80°; Alternatively, the connection surface 102 includes an intersecting beveled surface 1021, a first annular side surface 1022, a first side plane 1023, and a second side plane 1024. The intersection of the first side plane 1023 and the second side plane 1024 forms a first transition connection surface 1026. The angle between the beveled surface 1021 and the first transition connection surface 1026 ranges from 20° to 80°, and the angle between the beveled surface 1021 and the axis of the hollow microneedle 1 ranges from 20° to 80°. Alternatively, the connection surface 102 is a conical surface, and the liquid outlet 1011 is formed on the conical surface. The shape of the connection surface 102 can be various, and correspondingly, the shape of the needle tip 10 can also be various.

[0057] Specifically, the two sides of the first annular side surface 1022 are respectively intersected and connected with the first side plane 1023 and the second side plane 1024, the first side plane 1023 and the second side plane 1024 intersect at the first intersection line 1025, and the bevel surface 1021 intersects with the first annular side surface 1022, the first side plane 1023 and the second side plane 1024. At this time, the projection shape of the needle tip 10 on the horizontal plane is a teardrop shape; the place where the first side plane 1023 and the second side plane 1024 intersect can also form a first transition connection surface 1026, which can reduce the difficulty of the processing technology; the connecting surface 102 can also be a conical surface, and the conical surface can include a triangular pyramid surface, a square pyramid surface, a pentagonal pyramid surface, a circular cone surface, etc. At this time, the needle tip 10 correspondingly forms a triangular pyramid, a square pyramid, a pentagonal pyramid, and a circular pyramid structure, and the projection shape of the needle tip 10 on the horizontal plane is a triangle or a polygon. The angle range between the beveled surface 1021 and the first intersection line 1025 or the first transition connection surface 1026 is limited to 20° to 80°, and the angle range between the beveled surface 1021 and the axis of the hollow microneedle 1 is limited to 20° to 80°, which can ensure that the angle of the liquid when it is emitted from the liquid outlet 1011 is within a reasonable range, thereby reducing the risk of leakage.

[0058] In the embodiment of the present application, the length of the second liquid flow channel 111 is greater than or equal to 100 μm, and the total volume of the first liquid flow channel 101 and the second liquid flow channel 111 accounts for 30%-80% of the total volume of the needle tip 10 and the needle shaft 11. By limiting the flow channel structure as described above, the delivery volume of the liquid medicine is effectively ensured to be within a reasonable range, avoiding leakage caused by excessive liquid medicine delivery due to an excessively large flow channel volume, and also avoiding insufficient liquid medicine delivery due to an excessively small flow channel volume.

[0059] As shown in Figures 1 to 3, in the embodiments of the present application, the first end of the needle shaft 11 faces the needle hub 12, and the second end of the needle shaft 11 faces the needle tip 10. The radial cross-sectional area of ​​the needle shaft 11 decreases from the first end to the second end. This structure reduces the initial contact area between the needle shaft 11 and the skin, increases pressure, and facilitates skin penetration. The needle shaft 11 can be a single-piece structure or a composite structure composed of multiple parts.

[0060] As shown in Figures 3 to 5, in the embodiments of the present application, the needle shaft 11 has a conical structure, which includes a second annular side surface 114, a third side plane 115, and a fourth side plane 116 that are connected and surrounded. The third side plane 115 and the fourth side plane 116 intersect at a second intersection line 117, which is parallel to the axis of the hollow microneedle 1, and the second annular side surface 114 is inclined toward the second intersection line 117. Alternatively, a second transition connection surface 118 is formed at the intersection of the third side plane 115 and the fourth side plane 116, which is parallel to the axis of the hollow microneedle 1, and the second annular side surface 114 is inclined toward the second transition connection surface 118. The needle shaft 11 with a truncated cone structure is integral, and its radial cross-sectional area decreases gradually. The two sides of the second annular side surface 114 intersect and connect with the third side plane 115 and the fourth side plane 116 respectively. The third side plane 115 and the fourth side plane 116 intersect at the second intersection line 117. In this way, the second annular side surface 114, the third side plane 115 and the fourth side plane 116 enclose a cone surface. The intersection of the third side plane 115 and the fourth side plane 116 can also form a second transition connection surface 118, which can reduce the difficulty of the processing technology. The second intersection line 117 or the second transition connection surface 118 is parallel to the axis of the hollow microneedle 1. The second annular side surface 114 is inclined toward the second intersection line 117 or the second transition connection surface 118. The entire needle rod 11 has a structural feature of being thick at the bottom and thin at the top. Furthermore, the angle between the second annular side surface 114 and the axis of the hollow microneedle 1 does not exceed 80°.

[0061] As shown in FIG. 3 and FIG. 4 , in the embodiment of the present application, the first intersection line 1025 and the second intersection line 117 are collinear.

[0062] As shown in FIG. 5 , in an embodiment of the present application, the first transition connection surface 1026 and the second transition connection surface 118 may be connected to form a whole surface.

[0063] As shown in FIG1 , in an embodiment of the present application, the needle bar 11 includes at least two main bodies; at least one main body has a different rate of change in radial cross-sectional area than the other main bodies, or all main bodies have the same rate of change in radial cross-sectional area. The needle bar 11 may be composed of a plurality of main bodies, each of which has a varying radial cross-sectional area, and the rates of change in radial cross-sectional area between the main bodies may be the same or different.

[0064] In the embodiments of the present application, the radial cross-sectional area of ​​the main body can also be constant. The main body can be a truncated cone, a cylinder, a polygonal pyramid, or a combination of the above shapes. The structure of the needle bar 11 shown in Figure 1 includes a pyramid with a variable radial cross-sectional area and a prism with a constant radial cross-sectional area.

[0065] As shown in Figures 1 to 3, in an embodiment of the present application, the first end of the needle hub 12 faces away from the needle rod 11, and the second end of the needle hub 12 faces the needle rod 11; the radial cross-sectional area of ​​the first end of the needle hub 12 is greater than or equal to the radial cross-sectional area of ​​the second end of the needle hub 12; the radial cross-sectional area of ​​the second end of the needle hub 12 is greater than or equal to the radial cross-sectional area of ​​the first end of the needle rod 11; the diameter of the first end of the needle hub 12 is greater than or equal to 200μm, and the distance between the first end of the needle hub 12 and the second end of the needle hub 12 is greater than or equal to 100μm. The overall shape of the needle hub 12 is a boss shape, which may include structures such as a cylinder, a truncated cone, a prism, and a truncated pyramid, which is not specifically limited in the embodiment of the present application. The distance between the first end of the needle hub 12 and the second end of the needle hub 12 is the height of the needle hub 12, and the height is greater than or equal to 100μm to ensure the structural strength of the needle hub 12.

[0066] Furthermore, a transition portion may be provided between the needle hub 12 and the needle shaft 11, wherein the radial cross-sectional area of ​​the transition portion decreases smoothly in a curved manner toward the needle shaft 11. The maximum diameter of the transition portion is less than or equal to the radial cross-sectional area of ​​the second end of the needle hub 12, and the minimum diameter of the transition portion is greater than or equal to the radial cross-sectional area of ​​the first end of the needle shaft 11. The needle shaft 11, transition portion, and needle hub 12 may be directly integrally formed.

[0067] When hollow microneedle 1 penetrates the skin, the contact between needle hub 12 and the skin prevents it from penetrating deeper into the skin, particularly the subcutaneous layer, after reaching a certain depth. This prevents bleeding and pain. Furthermore, when hollow microneedle 1 penetrates the skin, the skin's force on hollow microneedle 1 is transmitted sequentially from needle tip 10 and needle shaft 11 to needle hub 12. Furthermore, the presence of the transition connection also forms a transition chamfer 113, creating a smooth transition. This reduces stress concentration and the risk of needle breakage, increases the structural strength of hollow microneedle 1, and protects the skin.

[0068] In the embodiment of the present application, the diameter D of the first end of the needle rod 11 is in the range of 10-200 μm, the total length L of the needle tip 10 and the needle rod 11 is in the range of 200-1000 μm, and L / D≥2.

[0069] Furthermore, in one embodiment of the present application, the total length L of the needle tip 10 and the needle shaft 11 ranges from 300 μm to 800 μm, and the diameter D of the first end of the needle shaft 11 ranges from 50 μm to 150 μm.

[0070] As shown in Figures 6 to 8 , a second embodiment of the present application provides a microneedle array chip 2 comprising a base 20 and at least two hollow microneedles 1 according to any of the first embodiments. A cavity suitable for containing a liquid medicine is formed within the base 20, and the hollow microneedles 1 are disposed within the base 20. The cavity is connected to a third liquid flow channel 121.

[0071] The base 20 can be any carrier capable of supporting the hollow microneedles 1, or a container for storing drugs, with its cavity containing liquid medicine. The base 20 can be integrally formed with the hollow microneedles 1, and the hollow microneedles 1 are fixed to the base 20 via the needle holder 12. Multiple hollow microneedles 1 are distributed in an array on the base 20. When piercing the skin, the skin will produce a depression due to the effect of skin surface tension. Therefore, the center-to-center spacing between adjacent hollow microneedles 1 should be larger than the size of the skin depression, otherwise the hollow microneedles 1 will have difficulty penetrating the skin. Accordingly, in the embodiment of the present application, the center-to-center spacing between adjacent hollow microneedles 1 is greater than 1.5 mm. When the hollow microneedle 1 penetrates the skin, the force exerted by the skin on the hollow microneedle 1 is transmitted from the needle tip 10, the needle rod 11, the needle seat 12 to the base 20 in sequence. The size from the needle rod 11 to the needle seat 12 and then to the base 20 will not increase suddenly, and the existence of the transition connection part can also form a transition chamfer structure, which provides a smooth transition, reduces hazards such as stress concentration, reduces the risk of needle breakage, increases the structural strength of the hollow microneedle 1 on the base 20, and also protects the skin.

[0072] According to the microneedle array chip 2 provided in the embodiment of the second aspect of the present application, the hollow microneedle 1 on its base 20 includes a needle tip 10, a needle rod 11 and a needle seat 12. The needle tip 10, the needle rod 11 and the needle seat 12 are connected in sequence along the axial direction of the hollow microneedle 1, and a transition chamfer 113 is formed at the connection between the needle rod 11 and the needle seat 12. This can make the transition between the needle rod 11 and the needle seat 12 smooth, reduce the stress concentration at the connection between the needle rod 11 and the needle seat 12, and thus avoid the hollow microneedle 1 from breaking at the connection between the needle rod 11 and the needle seat 12 during the process of piercing the skin, thereby reducing the risk of needle breakage and enhancing the structural strength of the hollow microneedle 1; a first liquid flow channel 101 is formed in the needle tip 10, and a second liquid flow channel 111 is formed in the needle rod 11 , a third liquid flow channel 121 is formed in the needle seat 12, and the first liquid flow channel 101, the second liquid flow channel 111 and the third liquid flow channel 121 are connected to facilitate the circulation of the liquid medicine. The liquid medicine passes through the third liquid flow channel 121, the second liquid flow channel 111 and the first liquid flow channel 101 in turn, and flows out of the first liquid flow channel 101, wherein the angle between the first central axis of the first liquid flow channel 101 and the second central axis of the second liquid flow channel 111 ranges from 0° to 80°, and the exit angle of the liquid medicine when flowing through the first liquid flow channel 101 is diversified in design, and the direction of liquid flow changes, which can reduce the flow velocity and pressure, thereby reducing the risk of seepage, and can better release the liquid medicine into the skin tissue. In summary, the microneedle array chip 2 provided in the embodiment of the present application and the hollow microneedle 1 have good overall structural strength, and can reduce the risk of drug seepage and improve drug delivery efficiency.

[0073] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present application, rather than to limit them. Although the present application has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present application.

Claims

1. A hollow microneedle (1), comprising: A needle tip (10), a needle shaft (11) and a needle seat (12), wherein the needle tip (10), the needle shaft (11) and the needle seat (12) are sequentially connected along the axial direction of the hollow microneedle (1), and a transition chamfer (113) is formed at the connection between the needle shaft (11) and the needle seat (12); A first liquid flow channel (101) is formed in the needle tip (10), a second liquid flow channel (111) is formed in the needle rod (11), and a third liquid flow channel (121) is formed in the needle seat (12); The first liquid flow channel (101), the second liquid flow channel (111) and the third liquid flow channel (121) are connected; The angle between the first central axis of the first liquid flow channel (101) and the second central axis of the second liquid flow channel (111) ranges from 0° to 80°.

2. The hollow microneedle (1) according to claim 1, wherein: The end of the needle tip (10) facing away from the needle rod (11) forms a pointed top, and the end of the needle tip (10) facing the needle rod (11) forms a pointed bottom, and the radial cross-sectional area of ​​the needle tip (10) decreases from the pointed bottom to the pointed top; A connecting surface (102) is formed between the pointed top portion and the pointed bottom portion, and a liquid outlet (1011) of the first liquid flow channel (101) is formed on the connecting surface (102).

3. The hollow microneedle (1) according to claim 2, wherein: The connecting surface (102) comprises an intersecting chamfered surface (1021), a first annular side surface (1022), a first side plane (1023) and a second side plane (1024), the first side plane (1023) and the second side plane (1024) intersecting at a first intersection line (1025), the liquid outlet (1011) is formed on the chamfered surface (1021), the angle between the chamfered surface (1021) and the first intersection line (1025) ranges from 20° to 80°, and the angle between the chamfered surface (1021) and the axis of the hollow microneedle (1) ranges from 20° to 80°; Alternatively, the connecting surface (102) includes an intersecting chamfered surface (1021), a first annular side surface (1022), a first side plane (1023) and a second side plane (1024), wherein a first transition connecting surface (1026) is formed at the intersection of the first side plane (1023) and the second side plane (1024), and an angle between the chamfered surface (1021) and the first transition connecting surface (1026) is in a range of 20° to 80°, and the chamfered surface (1021) and the hollow microneedle are (1) The angle between the axes ranges from 20° to 80°; Alternatively, the connecting surface (102) is a conical surface, and the liquid outlet (1011) is formed on the conical surface.

4. The hollow microneedle (1) according to claim 1, wherein: The length of the second liquid flow channel (111) is greater than or equal to 100 μm; The total volume of the first liquid flow channel (101) and the second liquid flow channel (111) accounts for 30%-80% of the total volume of the needle tip (10) and the needle rod (11).

5. The hollow microneedle (1) according to any one of claims 1 to 4, wherein: The first end of the needle rod (11) faces the needle seat (12), and the second end of the needle rod (11) faces the needle tip (10). The radial cross-sectional area of ​​the needle rod (11) decreases from the first end of the needle rod (11) to the second end of the needle rod (11).

6. The hollow microneedle (1) according to claim 5, wherein: The needle rod (11) is a cone structure, and the cone includes a second annular side surface (114), a third side plane (115) and a fourth side plane (116) which are connected and surrounded; The third side plane (115) intersects with the fourth side plane (116) at a second intersection line (117), the second intersection line (117) is parallel to the axis of the hollow microneedle (1), and the second annular side surface (114) is inclined toward the second intersection line (117); Alternatively, a second transition connection surface (118) is formed at the intersection of the third side plane (115) and the fourth side plane (116), the second transition connection surface (118) is parallel to the axis of the hollow microneedle (1), and the second annular side surface (114) is inclined toward the second transition connection surface (118).

7. The hollow microneedle (1) according to claim 5, wherein: The needle rod (11) comprises at least two main body parts; The radial cross-sectional area change rate of at least one of the main body portions is different from the radial cross-sectional area change rates of the other main body portions, or the radial cross-sectional area change rates of all the main body portions are the same.

8. The hollow microneedle (1) according to claim 5, wherein: The first end of the needle seat (12) faces away from the needle rod (11), and the second end of the needle seat (12) faces the needle rod (11); The radial cross-sectional area of ​​the first end of the needle seat (12) is greater than or equal to the radial cross-sectional area of ​​the needle seat (12). a radial cross-sectional area of ​​a second end of The radial cross-sectional area of ​​the second end of the needle seat (12) is greater than or equal to the radial cross-sectional area of ​​the first end of the needle rod (11); The diameter of the first end of the needle seat (12) is greater than or equal to 200 μm, and the distance between the first end of the needle seat (12) and the second end of the needle seat (12) is greater than or equal to 100 μm.

9. The hollow microneedle (1) according to claim 5, wherein: The diameter D of the first end of the needle rod (11) is in the range of 10-200 μm, the total length L of the needle tip (10) and the needle rod (11) is in the range of 200-1000 μm, and L / D≥2.

10. A microneedle array chip (2), comprising: A base (20), wherein a receiving cavity suitable for receiving a medicinal liquid is formed in the base (20); as well as At least two hollow microneedles (1) according to any one of claims 1 to 9, Wherein, the hollow microneedle (1) is arranged on the base (20), and the accommodating cavity is connected to the third liquid flow channel (121).

Citation Information

Patent Citations

  • Microfluidic devices and fabrication

    CN107073210A

  • Ultramicro needle piece for enhancing utilization rate of needle bar

    CN114177513A

  • Wheat-ear-shaped bionic porous microneedle transdermal drug delivery system

    CN115154876A

  • Soluble hollow microneedle, microneedle array chip and transdermal drug delivery patch

    CN117547725A

  • Hollow microneedle and microneedle array chip

    CN220276122U

Cited By

  • Hollow microneedle

    CN119424893A